(WRB) W. R. Berkley - Ratings and Ratios
Commercial Insurance, Reinsurance, Excess, Specialty, Casualty
WRB EPS (Earnings per Share)
WRB Revenue
Description: WRB W. R. Berkley October 14, 2025
W. R. Berkley Corp. (NYSE: WRB) is a U.S.–based insurance holding company that writes commercial lines worldwide through two primary segments: Insurance, and Reinsurance & Monoline Excess.
The **Insurance** segment underwrites a broad mix of commercial coverages-including excess and surplus lines, admitted lines, specialty personal lines, and niche products such as fine-arts, cyber-risk, and life-sciences insurance. It also offers accident-and-health, workers’ compensation, and various liability policies (e.g., D&O, professional liability, EPLI) to small- and medium-sized insureds, plus a suite of personal-lines products (home, auto, collector-vehicle). The segment additionally provides at-risk and alternative-risk program management services and writes business for the Lloyd’s market.
The **Reinsurance & Monoline Excess** segment delivers treaty and facultative reinsurance across property-and-casualty lines, including automatic, semi-automatic, and individual-risk arrangements. It also markets turnkey solutions for cyber, employment-practices liability, liquor-liability, and violent-event exposures.
Key financial metrics (as of FY 2023) show a **combined ratio of 92.5%**, indicating underwriting profitability, and a **return on equity (ROE) of 14.2%**, well above the industry median of ~9%. The company’s **risk-based capital (RBC) ratio stood at 300%**, reflecting a strong capital buffer amid a hardening reinsurance market. These figures suggest WRB is positioned to capture upside from rising premium volumes while maintaining disciplined risk management.
Macro-level drivers that materially affect WRB’s outlook include: (1) **interest-rate environments**, which influence investment income that historically accounts for ~30% of total earnings for property-and-casualty carriers; (2) **commercial insurance demand** tied to U.S. business-investment cycles and the ongoing expansion of technology-heavy sectors that require specialized cyber and professional-liability coverages; and (3) **climate-related loss trends**, which are reshaping pricing and capacity in property reinsurance and could elevate the value of WRB’s reinsurance-excess capabilities.
From a sector perspective, the **hardening cycle in property-and-casualty reinsurance**-driven by constrained capacity and elevated loss reserves-has been pushing ceding insurers to seek excess and monoline solutions, a niche where WRB’s Reinsurance & Monoline segment is well-aligned.
For analysts looking to deepen their quantitative assessment, a useful next step is to compare WRB’s **price-to-book (P/B) ratio** and **embedded value** against peers such as Chubb (CB) and Alleghany (Y) to gauge relative market pricing and hidden upside.
**If you want a data-rich, model-ready view of WRB’s valuation dynamics, ValueRay’s platform offers granular financials and scenario analytics that can help you test these hypotheses further.**
WRB Stock Overview
| Market Cap in USD | 28,582m |
| Sub-Industry | Property & Casualty Insurance |
| IPO / Inception | 1984-09-07 |
WRB Stock Ratings
| Growth Rating | 87.0% |
| Fundamental | 80.1% |
| Dividend Rating | 66.3% |
| Return 12m vs S&P 500 | 10.1% |
| Analyst Rating | 3.56 of 5 |
WRB Dividends
| Dividend Yield 12m | 1.78% |
| Yield on Cost 5y | 5.49% |
| Annual Growth 5y | 60.79% |
| Payout Consistency | 93.6% |
| Payout Ratio | 25.8% |
WRB Growth Ratios
| Growth Correlation 3m | 89.7% |
| Growth Correlation 12m | 87.8% |
| Growth Correlation 5y | 93.9% |
| CAGR 5y | 17.60% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.67 |
| CAGR/Mean DD 3y (Pain Ratio) | 2.26 |
| Sharpe Ratio 12m | 1.72 |
| Alpha | 19.08 |
| Beta | 0.417 |
| Volatility | 22.13% |
| Current Volume | 2289.9k |
| Average Volume 20d | 2113.3k |
| Stop Loss | 73 (-3%) |
| Signal | 0.25 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (1.91b TTM) > 0 and > 6% of Revenue (6% = 879.2m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -0.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 214.3% (prev 240.5%; Δ -26.20pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.50b > Net Income 1.91b (YES >=105%, WARN >=100%) |
| Net Debt (866.2m) to EBITDA (2.53b) ratio: 0.34 <= 3.0 (WARN <= 3.5) |
| Current Ratio 47.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (400.2m) change vs 12m ago -0.40% (target <= -2.0% for YES) |
| Gross Margin 20.98% (prev 22.72%; Δ -1.74pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 34.86% (prev 32.69%; Δ 2.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.83 (EBITDA TTM 2.53b / Interest Expense TTM 127.0m) >= 6 (WARN >= 3) |
Altman Z'' 6.26
| (A) 0.72 = (Total Current Assets 32.08b - Total Current Liabilities 668.7m) / Total Assets 43.72b |
| (B) 0.28 = Retained Earnings (Balance) 12.27b / Total Assets 43.72b |
| (C) 0.04 = EBIT TTM 1.88b / Avg Total Assets 42.04b |
| (D) 0.32 = Book Value of Equity 10.18b / Total Liabilities 32.16b |
| Total Rating: 6.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 80.05
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 11.66% = 5.0 |
| 3. FCF Margin 23.44% = 5.86 |
| 4. Debt/Equity 0.34 = 2.44 |
| 5. Debt/Ebitda 0.34 = 2.41 |
| 6. ROIC - WACC (= 5.76)% = 7.20 |
| 7. RoE 21.76% = 1.81 |
| 8. Rev. Trend 96.88% = 7.27 |
| 9. EPS Trend -28.91% = -1.45 |
What is the price of WRB shares?
Over the past week, the price has changed by +2.42%, over one month by -1.00%, over three months by +10.81% and over the past year by +31.47%.
Is W. R. Berkley a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WRB is around 83.20 USD . This means that WRB is currently undervalued and has a potential upside of +10.55% (Margin of Safety).
Is WRB a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the WRB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.8 | -0.6% |
| Analysts Target Price | 74.8 | -0.6% |
| ValueRay Target Price | 91.5 | 21.6% |
WRB Fundamental Data Overview October 25, 2025
P/E Trailing = 15.8067
P/E Forward = 15.748
P/S = 1.9505
P/B = 3.1088
P/EG = 11.2426
Beta = 0.417
Revenue TTM = 14.65b USD
EBIT TTM = 1.88b USD
EBITDA TTM = 2.53b USD
Long Term Debt = 2.84b USD (from longTermDebt, last fiscal year)
Short Term Debt = 24.5m USD (from shortTermDebt, two quarters ago)
Debt = 2.84b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 866.2m USD (from netDebt column, last fiscal year)
Enterprise Value = 29.45b USD (28.58b + Debt 2.84b - CCE 1.97b)
Interest Coverage Ratio = 14.83 (Ebit TTM 1.88b / Interest Expense TTM 127.0m)
FCF Yield = 11.66% (FCF TTM 3.43b / Enterprise Value 29.45b)
FCF Margin = 23.44% (FCF TTM 3.43b / Revenue TTM 14.65b)
Net Margin = 13.01% (Net Income TTM 1.91b / Revenue TTM 14.65b)
Gross Margin = 20.98% ((Revenue TTM 14.65b - Cost of Revenue TTM 11.58b) / Revenue TTM)
Gross Margin QoQ = 18.23% (prev 18.42%)
Tobins Q-Ratio = 0.67 (Enterprise Value 29.45b / Total Assets 43.72b)
Interest Expense / Debt = 1.12% (Interest Expense 31.8m / Debt 2.84b)
Taxrate = 21.01% (136.1m / 648.1m)
NOPAT = 1.49b (EBIT 1.88b * (1 - 21.01%))
Current Ratio = 47.97 (Total Current Assets 32.08b / Total Current Liabilities 668.7m)
Debt / Equity = 0.34 (Debt 2.84b / totalStockholderEquity, last fiscal year 8.40b)
Debt / EBITDA = 0.34 (Net Debt 866.2m / EBITDA 2.53b)
Debt / FCF = 0.25 (Net Debt 866.2m / FCF TTM 3.43b)
Total Stockholder Equity = 8.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.36% (Net Income 1.91b / Total Assets 43.72b)
RoE = 21.76% (Net Income TTM 1.91b / Total Stockholder Equity 8.76b)
RoCE = 16.24% (EBIT 1.88b / Capital Employed (Equity 8.76b + L.T.Debt 2.84b))
RoIC = 12.71% (NOPAT 1.49b / Invested Capital 11.71b)
WACC = 6.95% (E(28.58b)/V(31.42b) * Re(7.55%) + D(2.84b)/V(31.42b) * Rd(1.12%) * (1-Tc(0.21)))
Discount Rate = 7.55% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.78%
[DCF Debug] Terminal Value 80.21% ; FCFE base≈3.38b ; Y1≈3.89b ; Y5≈5.48b
Fair Price DCF = 249.0 (DCF Value 94.60b / Shares Outstanding 379.9m; 5y FCF grow 17.79% → 3.0% )
EPS Correlation: -28.91 | EPS CAGR: -1.91% | SUE: 0.63 | # QB: 0
Revenue Correlation: 96.88 | Revenue CAGR: 8.46% | SUE: 0.83 | # QB: 0
Additional Sources for WRB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle